Waters Corporation (U.S.), Agilent Technologies (U.S.), Metabolon, Inc. (U.S.), Shimadzu Corporation (Japan), Bruker Corporation (U.S.), and Biocrates Life Sciences AG. (Austria)
(PRWEB) October 13, 2014
The “Metabolomics Market - By Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, By Application (Biomarker & Drug Discovery, Nutrigenomics), By Indication (Oncology, Cardiology) – Global Forecast to 2019” analyses and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.
This report studies the metabolomics market over the forecast period of 2014 to 2019. The global metabolomics market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019
Get Inquiry for Further Details @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=900
The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibit the growth of the market to a certain extent.
In this report, the global metabolomics market is segmented based on techniques, applications, indications, and geography. Based on techniques, the metabolomics market is classified into Gas Chromatography, High Performance Liquid Chromatography (HPLC), Ultra Performance Liquid Chromatography (UPLC), Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS), and Surface-based Mass Analysis. The application market covers biomarker discovery, drug discovery/drug assessment, toxicology testing, nutrigenomics, and others. This report also discusses the key market drivers, restraints, and opportunities in the global metabolomics market and its sub-markets.
The global metabolomics market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibit the growth of the market to a certain extent.
During the forecast period, the high performance liquid chromatography (HPLC) segment will continue to drive and dominate the metabolomics market. The large share of the HPLC segment can be attributed to its wide application in biomarker discovery. By 2018, North America will continue to drive and dominate the metabolomics market, primarily due to the presence of major metabolomics companies in the U.S. Majority of the growth in the Asia-Pacific region is primarily driven by the growing pharmaceutical and biotechnology industries in this region. Developing technologies in Japan and China for drug discovery and early diagnosis of various diseases are expected to aid the growth of the APAC metabolomics market.
The metabolomics market is consolidated at the top, wherein the top 10 players accounted for nearly 75% of the market share in 2013. Majority of the leading players in the market are based in developed countries across North America and Europe.
The major players in the metabolomics market include Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Agilent Technologies (U.S.), Metabolon, Inc. (U.S.), Shimadzu Corporation (Japan), Bruker Corporation (U.S.), and Biocrates Life Sciences AG. (Austria). Collectively, the top five players accounted for nearly 75% of the global metabolomics market in 2013.
Ask for PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=900.
Thermo Fisher Scientific, Inc. (U.S.) and Danaher Corporation (U.S.) are the leading players in the market which together accounted for a share of around 40% to 45% in 2013. Thermo Fisher Scientific has a diversified product portfolio, which includes a wide range of analytical products, including liquid chromatography and gas chromatography systems. The company has a strong presence in over 150 countries through its strong manufacturing and distribution facilities, which enables it to cater to a large customer base across the globe. It focuses on strengthening and streamlining its product portfolio for the metabolomics market.
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza,
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn@ http://www.linkedin.com/company/marketsandmarkets